Skip to content

The study of effective treatment for in vitro maturation of immature human oocytes

The study of effective treatment for in vitro maturation of immature human oocytes - The study of effective treatment for in vitro maturation of immature human oocytes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013372
Enrollment
100
Registered
2014-03-07
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

To conduct intracytoplasmic sperm injection after in vitro maturation of immature oocytes.

Sponsors

Oak Clinic, Japan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients that require in vitro maturation of immature oocyte picked up after hCG treatment

Exclusion criteria

Exclusion criteria: Patients with serious underlying diseases

Design outcomes

Secondary

MeasureTime frame
Pregnancy rates

Primary

MeasureTime frame
Maturation rates, fertilization rates and embryo quality

Countries

Japan

Contacts

Public ContactSagiri Taguchi

Oak Clinic, Japan IVF Center

taguchi_s@oakclinic-group.com06-4398-1019

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026